Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Chinese Journal of Cancer Research
Published in: Chinese Journal of Cancer Research 1/2012

01-03-2012 | Original Article

Attributable causes of breast cancer and ovarian cancer in China: Reproductive factors, oral contraceptives and hormone replacement therapy

Authors: Li Li, Jia Ji, Jian-bing Wang, Mayineur Niyazi, You-lin Qiao, Paolo Boffetta

Published in: Chinese Journal of Cancer Research | Issue 1/2012

Login to get access
Metadata
Title
Attributable causes of breast cancer and ovarian cancer in China: Reproductive factors, oral contraceptives and hormone replacement therapy
Authors
Li Li
Jia Ji
Jian-bing Wang
Mayineur Niyazi
You-lin Qiao
Paolo Boffetta
Publication date
01-03-2012
Publisher
Chinese Anti-Cancer Association
Published in
Chinese Journal of Cancer Research / Issue 1/2012
Print ISSN: 1000-9604
Electronic ISSN: 1993-0631
DOI
https://doi.org/10.1007/s11670-012-0009-y

Other articles of this Issue 1/2012

Chinese Journal of Cancer Research 1/2012 Go to the issue

Original Article

Quality of life in cancer patients with pain in Beijing

Original Article

HLA class I expressions on peripheral blood mononuclear cells in colorectal cancer patients

Original Article

Caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis

Original Article

Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and Cathepsin L in diagnosis of ovarian cancer

Original Article

JAK2 V617F, MPL W515L and JAK2 exon 12 mutations in Chinese patients with primary myelofibrosis

Original Article

Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits